{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:32:31Z","timestamp":1791415951286,"version":"4.3.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-19-2-0020"],"award-info":[{"award-number":["W81XWH-19-2-0020"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-18-2-0040"],"award-info":[{"award-number":["W81XWH-18-2-0040"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-19-2-0020"],"award-info":[{"award-number":["W81XWH-19-2-0020"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-19-2-0020"],"award-info":[{"award-number":["W81XWH-19-2-0020"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Trudeau Institute, Inc. Internal fund, TRN-UPSOO."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Zika virus (ZIKV) is a significant threat to pregnant women and their fetuses as it can cause severe birth defects and congenital neurodevelopmental disorders, referred to as congenital Zika syndrome (CZS). Thus, a safe and effective ZIKV vaccine for pregnant women to prevent in utero ZIKV infection is of utmost importance. Murine models of ZIKV infection are limited by the fact that immunocompetent mice are resistant to ZIKV infection. As such, interferon-deficient mice have been used in some preclinical studies to test the efficacy of ZIKV vaccine candidates against lethal virus challenge. However, interferon-deficient mouse models have limitations in assessing the immunogenicity of vaccines, necessitating the use of immunocompetent mouse pregnancy models. Using the human\n                    <jats:italic>stat2<\/jats:italic>\n                    knock-in (hSTAT2KI) mouse pregnancy model, we show that vaccination with a purified formalin-inactivated Zika virus (ZPIV) vaccine prior to pregnancy successfully prevented vertical transmission. In addition, maternal immunity protected offspring against postnatal challenge for up to 28 days. Furthermore, passive transfer of human IgG purified from hyper-immune sera of ZPIV vaccinees prevented maternal and fetal ZIKV infection, providing strong evidence that the neutralizing antibody response may serve as a meaningful correlate of protection.\n                  <\/jats:p>","DOI":"10.1038\/s41541-024-00823-1","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T07:02:58Z","timestamp":1707980578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0408-9589","authenticated-orcid":false,"given":"In-Jeong","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3679-5688","authenticated-orcid":false,"given":"Michael P.","family":"Tighe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula A.","family":"Lanthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline J.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael A.","family":"De La Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8579-6356","authenticated-orcid":false,"given":"Vincent","family":"Dussupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letzibeth","family":"Mendez-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1136-1760","authenticated-orcid":false,"given":"Shelly J.","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3370-4819","authenticated-orcid":false,"given":"Kelsey L.","family":"Travis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7372-1605","authenticated-orcid":false,"given":"Timothy C.","family":"Low-Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1066-5036","authenticated-orcid":false,"given":"Tres S.","family":"Cookenham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3315-8547","authenticated-orcid":false,"given":"Kathleen G.","family":"Lanzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5934-2107","authenticated-orcid":false,"given":"Derek T.","family":"Bernacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"Szaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9172-0331","authenticated-orcid":false,"given":"Amanda A.","family":"Schneck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6350-8982","authenticated-orcid":false,"given":"Jerrold","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8368-7682","authenticated-orcid":false,"given":"Stephen J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6514-5572","authenticated-orcid":false,"given":"Kayvon","family":"Modjarrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6106-7490","authenticated-orcid":false,"given":"Marcia A.","family":"Blackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"key":"823_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/0035-9203(52)90043-6","volume":"46","author":"GW Dick","year":"1952","unstructured":"Dick, G. W. Zika virus. II. Pathogenicity and physical properties. Trans. R. Soc. Trop. Med. Hyg. 46, 521\u2013534, https:\/\/doi.org\/10.1016\/0035-9203(52)90043-6 (1952).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"823_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1056\/NEJMc1606769","volume":"375","author":"LR Petersen","year":"2016","unstructured":"Petersen, L. R., Jamieson, D. J. & Honein, M. A. Zika Virus. N. Engl. J. Med. 375, 294\u2013295, https:\/\/doi.org\/10.1056\/NEJMc1606769 (2016).","journal-title":"N. Engl. J. Med."},{"key":"823_CR3","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/S0140-6736(16)00651-6","volume":"387","author":"S Cauchemez","year":"2016","unstructured":"Cauchemez, S. et al. Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study. Lancet 387, 2125\u20132132, https:\/\/doi.org\/10.1016\/S0140-6736(16)00651-6 (2016).","journal-title":"Lancet"},{"key":"823_CR4","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1056\/NEJMoa1602412","volume":"375","author":"P Brasil","year":"2016","unstructured":"Brasil, P. et al. Zika virus infection in pregnant women in Rio de Janeiro. N. Engl. J. Med. 375, 2321\u20132334, https:\/\/doi.org\/10.1056\/NEJMoa1602412 (2016).","journal-title":"N. Engl. J. Med"},{"key":"823_CR5","doi-asserted-by":"publisher","first-page":"e1002203","DOI":"10.1371\/journal.pmed.1002203","volume":"14","author":"F Krauer","year":"2017","unstructured":"Krauer, F. et al. Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barre syndrome: systematic review. PLoS Med. 14, e1002203, https:\/\/doi.org\/10.1371\/journal.pmed.1002203 (2017).","journal-title":"PLoS Med."},{"key":"823_CR6","doi-asserted-by":"publisher","first-page":"i657","DOI":"10.1136\/bmj.i657","volume":"352","author":"A Gulland","year":"2016","unstructured":"Gulland, A. Zika virus is a global public health emergency, declares WHO. BMJ 352, i657, https:\/\/doi.org\/10.1136\/bmj.i657 (2016).","journal-title":"BMJ"},{"key":"823_CR7","unstructured":"PAHO. In www.paho.org (2016)."},{"key":"823_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-018-0061-9","volume":"3","author":"ADT Barrett","year":"2018","unstructured":"Barrett, A. D. T. Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation. NPJ Vaccines 3, 24, https:\/\/doi.org\/10.1038\/s41541-018-0061-9 (2018).","journal-title":"NPJ Vaccines"},{"key":"823_CR9","doi-asserted-by":"publisher","unstructured":"Wang, Y., Ling, L., Zhang, Z. & Marin-Lopez, A. Current advances in Zika vaccine development. Vaccines 10 https:\/\/doi.org\/10.3390\/vaccines10111816 (2022).","DOI":"10.3390\/vaccines10111816"},{"key":"823_CR10","doi-asserted-by":"publisher","first-page":"e2385","DOI":"10.1002\/rmv.2385","volume":"33","author":"M Yeasmin","year":"2023","unstructured":"Yeasmin, M., Molla, M. M. A., Masud, H. & Saif-Ur-Rahman, K. M. Safety and immunogenicity of Zika virus vaccine: a systematic review of clinical trials. Rev. Med. Virol. 33, e2385, https:\/\/doi.org\/10.1002\/rmv.2385 (2023).","journal-title":"Rev. Med. Virol."},{"key":"823_CR11","doi-asserted-by":"publisher","unstructured":"Abbink, P. et al. Durability and correlates of vaccine protection against Zika virus in rhesus monkeys. Sci. Transl. Med. 9 https:\/\/doi.org\/10.1126\/scitranslmed.aao4163 (2017).","DOI":"10.1126\/scitranslmed.aao4163"},{"key":"823_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-0167-8","volume":"5","author":"V Lecouturier","year":"2020","unstructured":"Lecouturier, V. et al. An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques. NPJ Vaccines 5, 19, https:\/\/doi.org\/10.1038\/s41541-020-0167-8 (2020).","journal-title":"NPJ Vaccines"},{"key":"823_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(17)33106-9","volume":"391","author":"K Modjarrad","year":"2018","unstructured":"Modjarrad, K. et al. Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials. Lancet 391, 563\u2013571, https:\/\/doi.org\/10.1016\/S0140-6736(17)33106-9 (2018).","journal-title":"Lancet"},{"key":"823_CR14","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S1473-3099(20)30085-2","volume":"20","author":"KE Stephenson","year":"2020","unstructured":"Stephenson, K. E. et al. Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial. Lancet Infect. Dis. 20, 1061\u20131070, https:\/\/doi.org\/10.1016\/S1473-3099(20)30085-2 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"823_CR15","doi-asserted-by":"publisher","unstructured":"Koren, M. A. et al. Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial. Lancet Infect. Dis. https:\/\/doi.org\/10.1016\/S1473-3099(23)00192-5 (2023).","DOI":"10.1016\/S1473-3099(23)00192-5"},{"key":"823_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00426-0","volume":"7","author":"IJ Kim","year":"2022","unstructured":"Kim, I. J. et al. Efficacy of an inactivated Zika vaccine against virus infection during pregnancy in mice and marmosets. NPJ Vaccines 7, 9, https:\/\/doi.org\/10.1038\/s41541-021-00426-0 (2022).","journal-title":"NPJ Vaccines"},{"key":"823_CR17","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.chom.2016.05.009","volume":"19","author":"A Grant","year":"2016","unstructured":"Grant, A. et al. Zika virus targets human STAT2 to inhibit type I interferon signaling. Cell Host Microbe 19, 882\u2013890, https:\/\/doi.org\/10.1016\/j.chom.2016.05.009 (2016).","journal-title":"Cell Host Microbe"},{"key":"823_CR18","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.chom.2018.04.003","volume":"23","author":"MJ Gorman","year":"2018","unstructured":"Gorman, M. J. et al. An immunocompetent mouse model of Zika virus infection. Cell Host Microbe 23, 672\u2013685.e676, https:\/\/doi.org\/10.1016\/j.chom.2018.04.003 (2018).","journal-title":"Cell Host Microbe"},{"key":"823_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3389\/fimmu.2020.00555","volume":"11","author":"M Albrecht","year":"2020","unstructured":"Albrecht, M. & Arck, P. C. Vertically transferred immunity in neonates: mothers, mechanisms and mediators. Front. Immunol. 11, 555, https:\/\/doi.org\/10.3389\/fimmu.2020.00555 (2020).","journal-title":"Front. Immunol."},{"key":"823_CR20","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.chom.2022.04.007","volume":"30","author":"SN Langel","year":"2022","unstructured":"Langel, S. N., Blasi, M. & Permar, S. R. Maternal immune protection against infectious diseases. Cell Host Microbe 30, 660\u2013674, https:\/\/doi.org\/10.1016\/j.chom.2022.04.007 (2022).","journal-title":"Cell Host Microbe"},{"key":"823_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13589-1","volume":"10","author":"C Shan","year":"2019","unstructured":"Shan, C. et al. Maternal vaccination and protective immunity against Zika virus vertical transmission. Nat. Commun. 10, 5677, https:\/\/doi.org\/10.1038\/s41467-019-13589-1 (2019).","journal-title":"Nat. Commun."},{"key":"823_CR22","doi-asserted-by":"publisher","first-page":"e1006994","DOI":"10.1371\/journal.ppat.1006994","volume":"14","author":"FM Szaba","year":"2018","unstructured":"Szaba, F. M. et al. Zika virus infection in immunocompetent pregnant mice causes fetal damage and placental pathology in the absence of fetal infection. PLoS Pathog. 14, e1006994, https:\/\/doi.org\/10.1371\/journal.ppat.1006994 (2018).","journal-title":"PLoS Pathog."},{"key":"823_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nature18296","volume":"534","author":"FR Cugola","year":"2016","unstructured":"Cugola, F. R. et al. The Brazilian Zika virus strain causes birth defects in experimental models. Nature 534, 267\u2013271, https:\/\/doi.org\/10.1038\/nature18296 (2016).","journal-title":"Nature"},{"key":"823_CR24","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.cell.2016.08.004","volume":"166","author":"LJ Yockey","year":"2016","unstructured":"Yockey, L. J. et al. Vaginal exposure to Zika virus during pregnancy leads to fetal brain infection. Cell 166, 1247\u20131256.e1244, https:\/\/doi.org\/10.1016\/j.cell.2016.08.004 (2016).","journal-title":"Cell"},{"key":"823_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14575","volume":"8","author":"MS Vermillion","year":"2017","unstructured":"Vermillion, M. S. et al. Intrauterine Zika virus infection of pregnant immunocompetent mice models transplacental transmission and adverse perinatal outcomes. Nat. Commun. 8, 14575, https:\/\/doi.org\/10.1038\/ncomms14575 (2017).","journal-title":"Nat. Commun."},{"key":"823_CR26","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.cell.2016.05.008","volume":"165","author":"JJ Miner","year":"2016","unstructured":"Miner, J. J. et al. Zika virus infection during pregnancy in mice causes placental damage and fetal demise. Cell 165, 1081\u20131091, https:\/\/doi.org\/10.1016\/j.cell.2016.05.008 (2016).","journal-title":"Cell"},{"key":"823_CR27","doi-asserted-by":"publisher","unstructured":"Yockey, L. J. et al. Type I interferons instigate fetal demise after Zika virus infection. Sci. Immunol. 3, https:\/\/doi.org\/10.1126\/sciimmunol.aao1680 (2018).","DOI":"10.1126\/sciimmunol.aao1680"},{"key":"823_CR28","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1002\/dvdy.20981","volume":"235","author":"PM Coan","year":"2006","unstructured":"Coan, P. M., Conroy, N., Burton, G. J. & Ferguson-Smith, A. C. Origin and characteristics of glycogen cells in the developing murine placenta. Dev. Dyn. 235, 3280\u20133294, https:\/\/doi.org\/10.1002\/dvdy.20981 (2006).","journal-title":"Dev. Dyn."},{"key":"823_CR29","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.placenta.2005.09.009","volume":"27","author":"S Bouillot","year":"2006","unstructured":"Bouillot, S., Rampon, C., Tillet, E. & Huber, P. Tracing the glycogen cells with protocadherin 12 during mouse placenta development. Placenta 27, 882\u2013888, https:\/\/doi.org\/10.1016\/j.placenta.2005.09.009 (2006).","journal-title":"Placenta"},{"key":"823_CR30","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000486841","volume":"60","author":"PD Yadav","year":"2017","unstructured":"Yadav, P. D. et al. Zika virus pathogenesis in infant mice after natural transmission by the bite of infected mosquitoes. Intervirology 60, 227\u2013234, https:\/\/doi.org\/10.1159\/000486841 (2017).","journal-title":"Intervirology"},{"key":"823_CR31","doi-asserted-by":"publisher","unstructured":"Rengifo, A. C. et al. Morphological and molecular changes in the cortex and cerebellum of immunocompetent mice infected with Zika virus. Viruses 15, https:\/\/doi.org\/10.3390\/v15081632 (2023).","DOI":"10.3390\/v15081632"},{"key":"823_CR32","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ajog.2021.10.041","volume":"226","author":"M Etti","year":"2022","unstructured":"Etti, M. et al. Maternal vaccination: a review of current evidence and recommendations. Am. J. Obstet. Gynecol. 226, 459\u2013474, https:\/\/doi.org\/10.1016\/j.ajog.2021.10.041 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"823_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bpobgyn.2020.09.005","volume":"76","author":"DW Mackin","year":"2021","unstructured":"Mackin, D. W. & Walker, S. P. The historical aspects of vaccination in pregnancy. Best. Pr. Res. Clin. Obstet. Gynaecol. 76, 13\u201322, https:\/\/doi.org\/10.1016\/j.bpobgyn.2020.09.005 (2021).","journal-title":"Best. Pr. Res. Clin. Obstet. Gynaecol."},{"key":"823_CR34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1600-0897.1996.tb00172.x","volume":"36","author":"A Malek","year":"1996","unstructured":"Malek, A., Sager, R., Kuhn, P., Nicolaides, K. H. & Schneider, H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am. J. Reprod. Immunol. 36, 248\u2013255, https:\/\/doi.org\/10.1111\/j.1600-0897.1996.tb00172.x (1996).","journal-title":"Am. J. Reprod. Immunol."},{"key":"823_CR35","doi-asserted-by":"publisher","first-page":"985646","DOI":"10.1155\/2012\/985646","volume":"2012","author":"P Palmeira","year":"2012","unstructured":"Palmeira, P., Quinello, C., Silveira-Lessa, A. L., Zago, C. A. & Carneiro-Sampaio, M. IgG placental transfer in healthy and pathological pregnancies. Clin. Dev. Immunol. 2012, 985646, https:\/\/doi.org\/10.1155\/2012\/985646 (2012).","journal-title":"Clin. Dev. Immunol."},{"key":"823_CR36","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.chom.2019.10.001","volume":"26","author":"RA Larocca","year":"2019","unstructured":"Larocca, R. A. et al. Adenovirus vector-based vaccines confer maternal-fetal protection against Zika virus challenge in pregnant IFN-alphabetaR(-\/-) mice. Cell Host Microbe 26, 591\u2013600.e594, https:\/\/doi.org\/10.1016\/j.chom.2019.10.001 (2019).","journal-title":"Cell Host Microbe"},{"key":"823_CR37","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3201\/eid1408.080287","volume":"14","author":"RS Lanciotti","year":"2008","unstructured":"Lanciotti, R. S. et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg. Infect. Dis. 14, 1232\u20131239, https:\/\/doi.org\/10.3201\/eid1408.080287 (2008).","journal-title":"Emerg. Infect. Dis."},{"key":"823_CR38","doi-asserted-by":"publisher","first-page":"112874","DOI":"10.1016\/j.jim.2020.112874","volume":"487","author":"M Merbah","year":"2020","unstructured":"Merbah, M. et al. A high-throughput multiplex assay to characterize flavivirus-specific immunoglobulins. J. Immunol. Methods 487, 112874, https:\/\/doi.org\/10.1016\/j.jim.2020.112874 (2020).","journal-title":"J. Immunol. Methods"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-00823-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-00823-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-00823-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T03:13:03Z","timestamp":1708312383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-024-00823-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["823"],"URL":"https:\/\/doi.org\/10.1038\/s41541-024-00823-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3158018\/v1","asserted-by":"object"}]},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,15]]},"assertion":[{"value":"10 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.J.T. is the lead inventor on the ZPIV patent filed by the US Army and assigned all rights to the US Government. Drs. M.A.B., I-J.K., and other authors have no competing interests. K.M. is currently an employee of Pfizer, Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}